InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Yared Nadim, Chairman & CEO. Director active across 1 companies, notably CVRx, Inc.. Aggregated, 9 reports have been published. The latest transaction was filed on 25 April 2022 — Levée d'options. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations9 total
€1,3406,059 shares@ €0.22120.0007% mcap16.7% of flow
Common Stock
SEC:0001415889-22-004278:0·
€5582,659 shares@ €0.20970.0003% mcap16.7% of flow
Common Stock
SEC:0001179110-22-000882·
€5582,659 shares@ €0.20970.0003% mcap7.0% of flow
Common Stock
SEC:0001179110-22-000882:0·
010,500 shares0
Common Stock
SEC:0001179110-22-000544·
010,500 shares0
Common Stock
SEC:0001179110-22-000544:0·
€4352,080 shares@ €0.20920.0002% mcap13.0% of flow
Common Stock
SEC:0001179110-21-011273·
€4352,080 shares@ €0.20920.0002% mcap5.4% of flow
Common Stock
SEC:0001179110-21-011273:0·
€2,34311,006 shares@ €0.21280.0013% mcap70.2% of flow
Common Stock
SEC:0001179110-21-010375·
€2,34311,006 shares@ €0.21280.0013% mcap29.2% of flow
Common Stock
SEC:0001179110-21-010375:0·
9 of 9 declarations
About Yared Nadim
Nadim Yared is the Chief Executive Officer of CVRx, Inc. As CEO, he leads the company in developing innovative medical solutions. CVRx, Inc. specializes in technologies for treating cardiovascular diseases. Yared is responsible for the overall strategy and innovation within the company.
